SAN MATEO, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Kronos Bio, Inc., a Two River portfolio company, today announced the appointment of Roger D. Kornberg, Ph.D., to its Scientific Advisory Board (SAB). Dr. Kornberg, a renowned biochemist, is Winzer Professor in Medicine in the Department of Structural Biology at Stanford University School of Medicine. He was awarded the Nobel Prize in Chemistry in 2006 for his studies of the molecular basis of eukaryotic transcription, the process by which DNA is copied to RNA.
“Dr. Kornberg’s scientific expertise will be invaluable as Kronos Bio advances its cutting-edge Small Molecule Microarray platform with the goal of discovering bioactive molecules against targets in oncology that historically have been considered ‘undruggable,’” said Owen Witte, M.D., chairman of the Kronos Bio SAB. “The addition of Dr. Kornberg to the Kronos Scientific Advisory Board strengthens an already accomplished group of scientific leaders who are experts in fields ranging from cancer biology and epigenetics to immunotherapy and personalized cancer therapies.”
“We are very excited to have Dr. Kornberg join our Scientific Advisory Board as we seek to enhance our discovery expertise,” said Norbert Bischofberger, Ph.D., President and Chief Executive Officer of Kronos. “Dr. Kornberg is widely respected visionary in our industry and as a fellow chemist, someone I hold in high regard. I look forward to leveraging his scientific counsel to advance potential therapies for patients.”
Dr. Kornberg has been a member of the faculty of Stanford University since 1972. Prior to that, he was a professor at Harvard Medical School. He was elected to the National Academy of Sciences in 1993 and is the recipient of several awards, including the 2001 Welch Prize, the highest award granted in the field of chemistry in the United States, and the 2002 Leopold Mayer Prize, the highest award granted in the field of biomedical sciences from the French Academy of Sciences. He earned a B.S. in chemistry from Harvard University and a Ph.D. in chemistry from Stanford University. He was a postdoctoral fellow and member of the scientific staff at the Laboratory of Molecular Biology in Cambridge, England, where he discovered the nucleosome, the basic unit of DNA coiling in chromosomes. Dr. Kornberg holds honorary degrees from universities in Europe and Israel, including the Hebrew University in Jerusalem, where he is currently a visiting professor.
Kronos Scientific Advisory Board
Kronos Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription.
# # #